Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (102) 102
science & technology (102) 102
life sciences & biomedicine (95) 95
male (95) 95
biological and medical sciences (77) 77
medical sciences (76) 76
oncology (73) 73
aged (63) 63
prostate cancer (60) 60
middle aged (55) 55
nephrology. urinary tract diseases (53) 53
tumors (48) 48
tumors of the urinary system (47) 47
urinary tract. prostate gland (46) 46
prostatic neoplasms - pathology (43) 43
prostatic neoplasms - drug therapy (30) 30
cancer (26) 26
risk factors (25) 25
prostatic neoplasms - genetics (23) 23
aged, 80 and over (22) 22
adult (21) 21
prostate-specific antigen - blood (21) 21
urology & nephrology (21) 21
research (20) 20
treatment outcome (20) 20
abridged index medicus (18) 18
gynecology. andrology. obstetrics (18) 18
prostatic neoplasms - mortality (18) 18
prospective studies (17) 17
prostate (17) 17
male genital diseases (16) 16
prognosis (16) 16
neoplasm staging (15) 15
care and treatment (14) 14
prostatic neoplasms - blood (14) 14
androgen antagonists - therapeutic use (13) 13
prostatic neoplasms - therapy (13) 13
chemotherapy (12) 12
cohort studies (12) 12
health aspects (12) 12
pharmacology. drug treatments (12) 12
genetic aspects (11) 11
metastases (11) 11
metastasis (11) 11
prostatic neoplasms - surgery (11) 11
antineoplastic agents (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
disease progression (10) 10
follow-up studies (10) 10
proportional hazards models (10) 10
antineoplastic agents - therapeutic use (9) 9
castration (9) 9
diagnosis (9) 9
time factors (9) 9
antineoplastic agents, hormonal - therapeutic use (8) 8
chemotherapy, adjuvant (8) 8
female (8) 8
gene expression (8) 8
immunotherapy (8) 8
prostatectomy (8) 8
prostatic neoplasms - metabolism (8) 8
retrospective studies (8) 8
adenocarcinoma - drug therapy (7) 7
biomarkers, tumor - blood (7) 7
development and progression (7) 7
disease-free survival (7) 7
kaplan-meier estimate (7) 7
medicin och hälsovetenskap (7) 7
prostatic neoplasms - diagnosis (7) 7
prostatic neoplasms - radiotherapy (7) 7
proteins (7) 7
urology (7) 7
usage (7) 7
analysis (6) 6
androgen antagonists - adverse effects (6) 6
androgens (6) 6
case-control studies (6) 6
confidence intervals (6) 6
genes (6) 6
genotype (6) 6
health risk assessment (6) 6
immunohistochemistry (6) 6
multidisciplinary sciences (6) 6
multivariate analysis (6) 6
mutation (6) 6
neoplasm metastasis (6) 6
orchiectomy (6) 6
prostatic neoplasms - immunology (6) 6
prostatic neoplasms, castration-resistant - drug therapy (6) 6
randomized controlled trials as topic (6) 6
risk (6) 6
science & technology - other topics (6) 6
survival rate (6) 6
androgen antagonists - administration & dosage (5) 5
androgen deprivation therapy (5) 5
animals (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
cancer vaccines - therapeutic use (5) 5
chromosomes (5) 5
deoxyribonucleic acid--dna (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study
by Ross, Robert W, MD and Galsky, Matthew D, MD and Scher, Howard I, Prof and Magidson, Jay, PhD and Wassmann, Karl, MBA and Lee, Gwo-Shu Mary, PhD and Katz, Leah, MD and Subudhi, Sumit K, MD and Anand, Aseem, MD and Fleisher, Martin, PhD and Kantoff, Philip W, Prof and Oh, William K, Prof
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 11, pp. 1105 - 1113
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prostatic Neoplasms - pathology | Prognosis | Prospective Studies | Humans | Middle Aged | Risk Factors | Male | Prostatic Neoplasms - therapy | Biomarkers, Tumor - blood | Inflammation - metabolism | Castration | Survival Analysis | Aged, 80 and over | Inflammation - genetics | Prostatic Neoplasms - blood | Aged | RNA - blood | Medical colleges | RNA | Analysis | Oncology, Experimental | Research | Prostate cancer | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study
by Schutz, Fabio AB, MD and Pomerantz, Mark M, MD and Gray, Kathryn P, PhD and Atkins, Michael B, Prof and Rosenberg, Jonathan E, MD and Hirsch, Michelle S, MD and McDermott, David F, MD and Lampron, Megan E, BS and Lee, Gwo-Shu Mary, MD and Signoretti, Sabina, MD and Kantoff, Philip W, Prof and Freedman, Matthew L, MD and Choueiri, Toni K, Dr
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 1, pp. 81 - 87
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Genetic Association Studies | Carcinoma, Renal Cell - pathology | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Renal Cell - genetics | Genotype | Male | Proto-Oncogene Proteins c-met - genetics | Neoplasm Recurrence, Local - pathology | Nephrectomy | Alleles | Polymorphism, Single Nucleotide - genetics | Female | Neoplasm Recurrence, Local - genetics | Aged | Cohort Studies | Relapse | Genetic aspects | Carcinoma | Chromosomes | Cancer | Diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Immunotherapy for Castration-Resistant Prostate Cancer
by Sonpavde, Guru and Kantoff, Philip W
Urologic clinics of North America, ISSN 0094-0143, 11/2012, Volume 39, Issue 4, pp. 465 - 481
PROSTVAC-VF TRICOM | Immune response | Sipuleucel-T, CTLA-4 | Immunotherapy | Castration-resistant | Overall survival | Prostate cancer | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Recombinant Fusion Proteins - immunology | Neoplasms, Hormone-Dependent - mortality | Prostatic Neoplasms - metabolism | Acid Phosphatase - immunology | Humans | Male | Tissue Extracts - therapeutic use | Listeria monocytogenes - immunology | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Randomized Controlled Trials as Topic | Cancer Vaccines - immunology | Neoplasms, Hormone-Dependent - therapy | Cancer Vaccines - therapeutic use | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Biomarkers, Tumor - metabolism
Journal Article
Details down arrow
4. Full Text Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer
by Toni K. Choueiri and Robert W. Ross and Susanna Jacobus and Ulka Vaishampayan and Evan Y. Yu and David I. Quinn and Noah M. Hahn and Thomas E. Hutson and Guru Sonpavde and Stephanie C. Morrissey and Geoffrey C. Buckle and William Y. Kim and Daniel P. Petrylak and Christopher W. Ryan and Mario A. Eisenberger and Amir Mortazavi and Glenn J. Bubley and Mary-Ellen Taplin and Jonathan E. Rosenberg and Philip W. Kantoff
Journal of clinical oncology, ISSN 0732-183X, 02/2012, Volume 30, Issue 5, pp. 507 - 512
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Multivariate Analysis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Urothelium - pathology | Urologic Neoplasms - pathology | Urologic Neoplasms - drug therapy | Treatment Failure | Adult | Female | Quinazolines - administration & dosage | Carcinoma - pathology | Taxoids - adverse effects | Carcinoma - drug therapy | Piperidines - administration & dosage | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Disease Progression | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Quinazolines - adverse effects | Aged | Platinum Compounds - administration & dosage | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus | ORIGINAL REPORTS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions
by Anthony V. D'Amico and James W. Denham and Juanita Crook and Ming-Hui Chen and Samuel Z. Goldhaber and David S. Lamb and David Joseph and Keen-Hun Tai and Shawn Malone and Charles Ludgate and Allison Steigler and Philip W. Kantoff
Journal of clinical oncology, ISSN 0732-183X, 06/2007, Volume 25, Issue 17, pp. 2420 - 2425
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Tumors | Myocardial Infarction - chemically induced | Myocardial Infarction - mortality | Prostatic Neoplasms - radiotherapy | Age Factors | Humans | Middle Aged | Risk Factors | Male | Aged | Androgen Antagonists - adverse effects | Prostatic Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The genomic complexity of primary human prostate cancer
by Berger, Michael F and Lawrence, Michael S and Demichelis, Francesca and Drier, Yotam and Cibulskis, Kristian and Sivachenko, Andrey Y and Sboner, Andrea and Esgueva, Raquel and Pflueger, Dorothee and Sougnez, Carrie and Onofrio, Robert and Carter, Scott L and Park, Kyung and Habegger, Lukas and Ambrogio, Lauren and Fennell, Timothy and Parkin, Melissa and Saksena, Gordon and Voet, Douglas and Ramos, Alex H and Pugh, Trevor J and Wilkinson, Jane and Fisher, Sheila and Winckler, Wendy and Mahan, Scott and Ardlie, Kristin and Baldwin, Jennifer and Simons, Jonathan W and Kitabayashi, Naoki and MacDonald, Theresa Y and Kantoff, Philip W and Chin, Lynda and Gabriel, Stacey B and Gerstein, Mark B and Golub, Todd R and Meyerson, Matthew and Tewari, Ashutosh and Lander, Eric S and Getz, Gad and Rubin, Mark A and Garraway, Levi A
Nature (London), ISSN 0028-0836, 02/2011, Volume 470, Issue 7333, pp. 214 - 220
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Fundamental and applied biological sciences. Psychology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Cell physiology | Molecular and cellular biology | Medical sciences | Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes | Male genital diseases | Tumors | Chromatin - metabolism | PTEN Phosphohydrolase - genetics | Cell Adhesion Molecules - genetics | Chromosome Breakpoints | Humans | Gene Expression Regulation, Neoplastic | PTEN Phosphohydrolase - metabolism | Male | Signal Transduction - genetics | Case-Control Studies | Genome, Human - genetics | Carrier Proteins - genetics | Prostatic Neoplasms - genetics | Epigenesis, Genetic - genetics | Chromosome Aberrations | Recombination, Genetic - genetics | Transcription, Genetic | Chromatin - genetics | Care and treatment | Genetic aspects | Prostate cancer | Health aspects | Genomics | Stem cells | Epigenetics | Gene loci | Genetic engineering | Mutation | Stress response | Chromosomes | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate Cancer
by Susan Halabi and Eric J. Small and Philip W. Kantoff and Michael W. Kattan and Ellen B. Kaplan and Nancy A. Dawson and Ellis G. Levine and Brent A. Blumenstein and Nicholas J. Vogelzang
Journal of clinical oncology, ISSN 0732-183X, 04/2003, Volume 21, Issue 7, pp. 1232 - 1237
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Prognosis | Humans | Risk Factors | Proportional Hazards Models | Drug Resistance, Neoplasm | Male | Models, Statistical | Prostatic Neoplasms - mortality | Neoplasm Metastasis | Androgen Antagonists - therapeutic use | ROC Curve | Aged | Adenocarcinoma - mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: Results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)
by Aggarwal, Rahul and Halabi, Susan and Kelly, William Kevin and George, Daniel and Mahoney, John F and Millard, Frederick and Stadler, Walter M and Morris, Michael J and Kantoff, Philip and Monk, J. Paul and Carducci, Michael and Small, Eric J and Alliance for Clinical Trials in Oncology and for the Alliance for Clinical Trials in Oncology
Cancer, ISSN 0008-543X, 10/2013, Volume 119, Issue 20, pp. 3636 - 3643
androgen antagonists | ketoconazole | chemotherapy | steroid 17-alpha-hydroxylase | prostatic neoplasms | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Bone Neoplasms - mortality | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Liver Neoplasms - mortality | Ketoconazole - pharmacology | Bevacizumab | Antibodies, Monoclonal, Humanized - administration & dosage | Lung Neoplasms - secondary | Retrospective Studies | Bone Neoplasms - drug therapy | Chemotherapy, Adjuvant | Drug Therapy, Combination | Liver Neoplasms - secondary | Prostatic Neoplasms - drug therapy | Antifungal Agents - pharmacology | Prostatic Neoplasms - pathology | Liver Neoplasms - drug therapy | Androgen Antagonists - pharmacology | Survival Rate | Lymphatic Metastasis | Disease Progression | Prostatic Neoplasms - mortality | Orchiectomy | Taxoids - administration & dosage | International Agencies | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Prednisone - pharmacology | Aged | Neoplasm Staging | Ketoconazole | Patient outcomes | Docetaxel | Antiandrogens | Dosage and administration | Research | Drug therapy | Prostate cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
by Nguyen, Paul L and Alibhai, Shabbir M.H and Basaria, Shehzad and D’Amico, Anthony V and Kantoff, Philip W and Keating, Nancy L and Penson, David F and Rosario, Derek J and Tombal, Bertrand and Smith, Matthew R
European urology, ISSN 0302-2838, 2014, Volume 67, Issue 5, pp. 825 - 836
Urology | Prostate cancer | Androgen deprivation therapy | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Gynecomastia - chemically induced | Humans | Male | Metabolic Diseases - chemically induced | Muscle Proteins - drug effects | Bone Diseases, Metabolic - chemically induced | Antineoplastic Agents, Hormonal - adverse effects | Body Composition - drug effects | Antineoplastic Agents, Hormonal - therapeutic use | Androgen Antagonists - therapeutic use | Cardiovascular Diseases - chemically induced | Quality of Life - psychology | Androgen Antagonists - adverse effects | Hot Flashes - chemically induced | Prostatic Neoplasms - drug therapy | Practice Guidelines as Topic | Medical policy | Physiological aspects | Medical colleges | Complications and side effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment
by Cooperberg, Matthew R and Broering, Jeannette M and Kantoff, Philip W and Carroll, Peter R
The Journal of urology, ISSN 0022-5347, 2007, Volume 178, Issue 3, pp. S14 - S19
Urology | questionnaires | risk factors | prostate | prognosis | prostatic neoplasms | Nephrology. Urinary tract diseases | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Prostatic Neoplasms - pathology | Prognosis | Risk Assessment | Humans | Risk Factors | Survival Analysis | Male | Prostatic Neoplasms - diagnosis | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Index Medicus | Abridged Index Medicus | CaPSURE | Prostatic neoplasms | Treatment | Risk factors | CAPRA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights